References
- Griese M. Chronic interstitial lung disease in children. Eur Respir Rev. 2018;27(147):170100. doi:10.1183/16000617.0100-2017.
- Fan LL. Evaluation and therapy of chronic interstitial pneumonitis in children. Curr Opin Pediatr. 1994;6(3):248–54. doi:10.1097/00008480-199406000-00004.
- Fan LL, Deterding RR, Langston C. Pediatric interstitial lung disease revisited. Pediatr Pulmonol. 2004;38(5):369–78. doi:10.1002/ppul.20114.
- Popler J, Lesnick B, Dishop MK, Deterding RR. New coding in the international classification of diseases, ninth revision, for children's interstitial lung disease. Chest. 2012;142(3):774–80. doi:10.1378/chest.12-0492.
- Nathan N, Berdah L, Borensztajn K, Clement A. Chronic interstitial lung diseases in children: diagnosis approaches. Expert Rev Respir Med. 2018;12(12):1051–60. doi:10.1080/17476348.2018.1538795.
- Dinwiddie R, Sharief N, Crawford O. Idiopathic interstitial pneumonitis in children: a national survey in the United Kingdom and Ireland. Pediatr Pulmonol. 2002;34(1):23–9. doi:10.1002/ppul.10125.
- Griese M, Haug M, Brasch F, Freihorst A, Lohse P, von Kries R, et al. Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany. Orphanet J Rare Dis. 2009;4:26. doi:10.1186/1750-1172-4-26.
- Watkin LB, Jessen B, Wiszniewski W, Vece TJ, Jan M, Sha Y, et al. COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis. Nat Genet. 2015;47(6):654–60. doi:10.1038/ng.3279.
- Tsui JL, Estrada OA, Deng Z, Wang KM, Law CS, Elicker BM, et al. Analysis of pulmonary features and treatment approaches in the COPA syndrome. ERJ Open Res. 2018;4(2):00017–2018. doi:10.1183/23120541.00017-2018.
- Vicary GW, Vergne Y, Santiago-Cornier A, Young LR, Roman J. Pulmonary fibrosis in hermansky-pudlak syndrome. Ann Am Thorac Soc. 2016;13(10):1839–46. doi:10.1513/AnnalsATS.201603-186FR.
- Balasubramanian M, Lord H, Levesque S, Guturu H, Thuriot F, Sillon G, et al. Chitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia results from a recurrent c.266A>G p.(Tyr89Cys) variant in the ERF gene. J Med Genet. 2017;54(3):157–65. doi:10.1136/jmedgenet-2016-104143.
- Du H, Guo Y, Ma D, Tang K, Cai D, Luo Y, et al. A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita. Medicine (Baltimore). 2018;97(19):e0724. doi:10.1097/MD.0000000000010724.
- Savage SA. Dyskeratosis congenita. 2009 Nov 12 [Updated 2016 May 26]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2018.
- Nattes E, Lejeune S, Carsin A, Borie R, Gibertini I, Balinotti J, et al. Heterogeneity of lung disease associated with NK2 homeo-box 1 mutations. Respir Med. 2017;129:16–23. doi:10.1016/j.rmed.2017.05.014.
- Sun Y, Hu G, Luo J, Fang D, Yu Y, Wang X, et al. Mutations in methionyl-tRNA synthetase gene in a Chinese family with interstitial lung and liver disease, postnatal growth failure and anemia. J Hum Genet. 2017;62(6):647–51. doi:10.1038/jhg.2017.10.
- Hadchouel A, Wieland T, Griese M, Baruffini E, Lorenz-Depiereux B, Enaud L, et al. Biallelic mutations of methionyl-tRNA synthetase cause a specific type of pulmonary alveolar proteinosis prevalent on Réunion Island. Am J Hum Genet. 2015;96(5):826–31. doi:10.1016/j.ajhg.2015.03.010.
- Xu Z, Lo WS, Beck DB, Schuch LA, Oláhová M, Kopajtich R, et al. Bi-allelic mutations in Phe-tRNA synthetase associated with a multi-system pulmonary disease support non-translational function. Am J Hum Genet. 2018;103(1):100–14. doi:10.1016/j.ajhg.2018.06.006.
- Krenke K, Szczałuba K, Bielecka T, Rydzanicz M, Lange J, Koppolu A, et al. FARSA mutations mimic phenylalanyl-tRNA synthetase deficiency caused by FARSB defects. Clin Genet. 2019;96(5):468–72. doi:10.1111/cge.13614.
- Escobar V, Weaver DD. Aarskog syndrome. New findings and genetic analysis. JAMA. 1978;240(24):2638–41. doi:10.1001/jama.240.24.2638.
- Taveira-DaSilva AM, Markello TC, Kleiner DE, Jones AM, Groden C, Macnamara E, et al. Expanding the phenotype of COPA syndrome: a kindred with typical and atypical features. J Med Genet. 2019;56(11):778–82. doi:10.1136/jmedgenet-2018-105560.
- Ammann S, Schulz A, Krägeloh-Mann I, Dieckmann NM, Niethammer K, Fuchs S, et al. Mutations in AP3D1 associated with immunodeficiency and seizures define a new type of Hermansky-Pudlak syndrome. Blood. 2016;127(8):997–1006. doi:10.1182/blood-2015-09-671636.
- Huizing M, Malicdan MCV, Gochuico BR, Gahl WA. Hermansky-Pudlak syndrome. 2000 Jul 24 [Updated 2017 Oct 26]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2019.
- Gahl WA, Brantly M, Kaiser-Kupfer MI, Iwata F, Hazelwood S, Shotelersuk V, et al. Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med. 1998;338(18):1258–64. doi:10.1056/NEJM199804303381803.
- Witkop CJ, Quevedo WC, Fitzpatrick TB, King RA. Albinism. In: Scriver CR, Beaudet AL, Sly WS, Valle DL, editors. The metabolic and molecular basis of inherited disease. 6th ed. Vol 2. New York, NY: McGraw-Hill; 1989. p. 2905–47.
- Chitayat D, Haj-Chahine S, Stalker HJ, Azouz EM, Côté A, Halal F. Hyperphalangism, facial anomalies, hallux valgus, and bronchomalacia: a new syndrome? Am J Med Genet. 1993;45(1):1–4. doi:10.1002/ajmg.1320450103.
- Milgrom H, Stoll HL Jr, Crissey JT. Dyskeratosis congenita. A case with new features. Arch Dermatol. 1964;89:345–9. doi:10.1001/archderm.1964.01590270031007. PMID: 14096348.
- Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood. 2006;107(7):2680–5. doi:10.1182/blood-2005-07-2622.
- Alter BP, Rosenberg PS, Giri N, Baerlocher GM, Lansdorp PM, Savage SA. Telomere length is associated with disease severity and declines with age in dyskeratosis congenita. Haematologica. 2012;97(3):353–9. doi:10.3324/haematol.2011.055269.
- Revesz T, Fletcher S, al Gazali LI, DeBuse P. Bilateral retinopathy, aplastic anaemia, and central nervous system abnormalities: a new syndrome? J Med Genet. 1992;29(9):673–5. doi:10.1136/jmg.29.9.673.
- Patel NJ, Jankovic J. NKX2-1-related disorders. 2014 Feb 20 [Updated 2016 Jul 29]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, et al. editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2018.
- Villafuerte B, Natera-de-Benito D, González A, Mori MA, Palomares M, Nevado J, et al. The Brain-Lung-Thyroid syndrome (BLTS): a novel deletion in chromosome 14q13.2-q21.1 expands the phenotype to humoral immunodeficiency. Eur J Med Genet. 2018;61(7):393–8. doi:10.1016/j.ejmg.2018.02.007.
- Gonzalez M, McLaughlin H, Houlden H, Guo M, Yo-Tsen L, Hadjivassilious M, et al. Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. J Neurol Neurosurg Psychiatry. 2013;84(11):1247–9. doi:10.1136/jnnp-2013-305049.
- Hyun YS, Park HJ, Heo SH, Yoon BR, Nam SH, Kim SB, et al. Rare variants in methionyl- and tyrosyl-tRNA synthetase genes in late-onset autosomal dominant Charcot-Marie-Tooth neuropathy. Clin Genet. 2014;86(6):592–4. doi:10.1111/cge.12327.
- Antonellis A, Oprescu SN, Griffin LB, Heider A, Amalfitano A, Innis JW. Compound heterozygosity for loss-of-function FARSB variants in a patient with classic features of recessive aminoacyl-tRNA synthetase-related disease. Hum Mutat. 2018;39(6):834–40. doi:10.1002/humu.23424.
- Zadjali F, Al-Yahyaee A, Al-Nabhani M, Al-Mubaihsi S, Gujjar A, Raniga S, et al. Homozygosity for FARSB mutation leads to Phe-tRNA synthetase-related disease of growth restriction, brain calcification, and interstitial lung disease. Hum Mutat. 2018;39(10):1355–9. doi:10.1002/humu.23595.
- Orrico A, Galli L, Clayton-Smith J, Fryns JP. Clinical utility gene card for: Aarskog-Scott Syndrome (faciogenital dysplasia) - update 2015. Eur J Hum Genet. 2015;23(4):558. doi:10.1038/ejhg.2014.178.
- Ahmed A, Mufeed A, Ramachamparambathu AK, Hasoon U. Identifying Aarskog syndrome. J Clin Diagn Res. 2016;10(12):ZD09-11. doi:10.7860/JCDR/2016/22180.8982.